Volker Arolt
Volker Arolt
Department Psychiatry, University of Muenster
Verified email at uni-muenster.de
Cited by
Cited by
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller, MJ Schwarz, S Dehning, A Douhe, A Cerovecki, ...
Molecular psychiatry 11 (7), 680-684, 2006
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
NR Wray, S Ripke, M Mattheisen, M Trzaskowski, EM Byrne, A Abdellaoui, ...
Nature genetics 50 (5), 668, 2018
Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging
U Dannlowski, A Stuhrmann, V Beutelmann, P Zwanzger, T Lenzen, ...
Biological psychiatry 71 (4), 286-293, 2012
S100B in brain damage and neurodegeneration
M Rothermundt, M Peters, JHM Prehn, V Arolt
Microscopy research and technique 60 (6), 614-632, 2003
Human fear conditioning and extinction in neuroimaging: a systematic review
C Sehlmeyer, S Schöning, P Zwitserlood, B Pfleiderer, T Kircher, V Arolt, ...
PloS one 4 (6), 2009
An international two–stage genome–wide search for schizophrenia susceptibility genes
HW Moises, L Yang, H Kristbjarnarson, C Wiese, W Byerley, F Macciardi, ...
Nature genetics 11 (3), 321, 1995
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo
PF Sullivan, EJC de Geus, G Willemsen, MR James, JH Smit, T Zandbelt, ...
Molecular psychiatry 14 (4), 359-375, 2009
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group
L Schmaal, DP Hibar, PG Sämann, GB Hall, BT Baune, N Jahanshad, ...
Molecular psychiatry 22 (6), 900-909, 2017
Automatic mood-congruent amygdala responses to masked facial expressions in major depression
T Suslow, C Konrad, H Kugel, D Rumstadt, P Zwitserlood, S Schöning, ...
Biological psychiatry 67 (2), 155-160, 2010
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression
M Ising, S Lucae, EB Binder, T Bettecken, M Uhr, S Ripke, MA Kohli, ...
Archives of general psychiatry 66 (9), 966-975, 2009
Cytokine production and serum proteins in depression
A Seidel, V Arolt, M Hunstiger, L Rink, A Behnisch, H Kirchner
Scandinavian journal of immunology 41 (6), 534-538, 1995
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients
B Pfleiderer, N Michael, A Erfurth, P Ohrmann, U Hohmann, M Wolgast, ...
Psychiatry Research: Neuroimaging 122 (3), 185-192, 2003
Maternal posttraumatic stress response after the birth of a very low-birth-weight infant
A Kersting, M Dorsch, U Wesselmann, K Lüdorff, J Witthaut, P Ohrmann, ...
Journal of psychosomatic research 57 (5), 473-476, 2004
Long-term cognitive and emotional consequences of mild traumatic brain injury
C Konrad, AJ Geburek, F Rist, H Blumenroth, B Fischer, I Husstedt, V Arolt, ...
Psychological medicine 41 (6), 1197-1211, 2011
Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease
V Arolt, R Lencer, A Nolte, B Müller‐Myhsok, S Purmann, M Schürmann, ...
American journal of medical genetics 67 (6), 564-579, 1996
Review of immunological and immunopathological findings in schizophrenia
M Rothermundt, V Arolt, TA Bayer
Brain, behavior, and immunity 15 (4), 319-339, 2001
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression
N Michael, A Erfurth, P Ohrmann, V Arolt, W Heindel, B Pfleiderer
Psychological medicine 33 (7), 1277-1284, 2003
Detection of facial expressions of emotions in depression
T Suslow, K Junghanns, V Arolt
Perceptual and motor skills 92 (3), 857-868, 2001
Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
AT Gloster, HU Wittchen, F Einsle, T Lang, S Helbig-Lang, T Fydrich, ...
Journal of consulting and clinical psychology 79 (3), 406, 2011
Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients
I Wilke, V Arolt, M Rothermundt, CH Weitzsch, M Hornberg, H Kirchner
European archives of psychiatry and clinical neuroscience 246 (5), 279-284, 1996
The system can't perform the operation now. Try again later.
Articles 1–20